Does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners?

ISRCTN	ISRCTN29854485
DOI	https://doi.org/10.1186/ISRCTN29854485
Secondary identifying numbers	N/A

Submission date: 04/04/2011
Registration date: 14/04/2011
Last edited: 06/09/2013

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Cancer

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nina Badertscher
Scientific

Institute of General Practice
University Hopsital Zurich
Pestalozzistrasse 24
Zürich
8091
Switzerland

Phone	+41 (0)44 255 39 83
Email	nina.badertscher@usz.ch

Study information

Study design	Single-centre randomised two-armed interventional study
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	GP practice
Study type	Diagnostic
Participant information sheet	Not available in web format, please use contact details below to request a GP or patient information sheet.
Scientific title	Does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners? A randomised controlled trial
Study acronym	minSKIN
Study objectives	A multifaceted intervention with general practitioners (GPs) (including technical equipment and a continuous feedback on skin lesions) leads to an improved competence in the diagnosis of skin cancer by GPs. On 06/09/2013 the target number of participants was changed from 60 to 78.
Ethics approval(s)	The ethics committee of the Kanton Zurich (Kantonale Ethik-Kommission Zürich) approved on the 01/03/2011 (KEK-ZH-NR: 2010-0384/5)
Health condition(s) or problem(s) studied	Skin cancer
Intervention	Both groups: Dermatological training course (duration: one day) Intervention group: 1. Magnifying glass (Lumio loupe) with integrated polarised light source allowing subsurface examination 2. Digital consumer camera 3. GPs send pictures of skin lesions to the study dermatologist and get continuous problem based feedback and teaching based on these pictures Control group: No further intervention, GPs provide usual care
Intervention type	Other
Primary outcome measure	Competence in the diagnosis of skin cancer by GPs, measured as the percentage of correctly classified pictures of skin lesions. The measures will be assessed at baseline before the dermatological workshop (T0), immediately after the dermatological workshop (T1) and after one year of continuous feedback with the intervention group (T2).
Secondary outcome measures	1. Histopathology of excised skin lesions 2. Age, sex and skin type of patients with skin lesions
Overall study start date	01/04/2011
Completion date	31/08/2012

Eligibility

Participant type(s)	Patient
Age group	Adult
Sex	All
Target number of participants	78 GPs
Key inclusion criteria	1. GPs in the Canton of Zurich 2. Provide basic medical care with a workload of at least 20 hours per week 3. Do not plan to retire or to move away during the study period
Key exclusion criteria	1. GPs from other Cantons than Zurich 2. Workload of less than 20 hours per week
Date of first enrolment	01/04/2011
Date of final enrolment	31/08/2012

Locations

Countries of recruitment

Switzerland

Study participating centre

Institute of General Practice

Zürich
8091
Switzerland

Sponsor information

Institute of General Practice - University of Zurich (Switzerland)
University/education

Institut für Hausarztmedizin der Universität Zürich
University Hospital of Zurich
Pestalozzistrasse 24
Zurich
8091
Switzerland

Phone	+41 (0)44 255 98 55
Email	thomas.rosemann@usz.ch
Website	http://www.hausarztmedizin.uzh.ch
"ROR"	https://ror.org/02crff812

Funders

Funder type

Other

Institute of General Practice - University of Zurich (Institut für Hausarztmedizin der Universität Zürich) (Switzerland)

No information available

Swiss Academy for Medical Sciences (SAMW) (Switzerland) (grant number RRMA 4-11)

No information available

MEDA Pharma AG (Switzerland)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Study outputs

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Protocol article	protocol	30/06/2011		Yes	No